Ayon, Salve S.
HRN: 21-40-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2022
MUPIROCIN 2%, 15G (TUBE)
10/09/2022
10/16/2022
TOPICAL
2 %
Q12H
Infected Wound Upper Back Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes